Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)
4.65 x 1 5.28 x 1
Post-market by (Cboe BZX)
4.74 -0.12 (-2.47%) 04/01/25 [NYSE]
4.65 x 1 5.28 x 1
Post-market 4.74 unch (unch) 16:04 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.63
Day High
4.96
Open 4.82
Previous Close 4.86 4.86
Volume 1,340,900 1,340,900
Avg Vol 1,272,775 1,272,775
Stochastic %K 12.50% 12.50%
Weighted Alpha -26.49 -26.49
5-Day Change -0.76 (-13.82%) -0.76 (-13.82%)
52-Week Range 1.82 - 15.10 1.82 - 15.10
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 264,078
  • Shares Outstanding, K 54,337
  • Annual Sales, $ 1,044 M
  • Annual Income, $ -190,600 K
  • EBIT $ -44 M
  • EBITDA $ 73 M
  • 60-Month Beta 1.80
  • Price/Sales 0.24
  • Price/Cash Flow 2.43
  • Price/Book 0.52

Options Overview Details

View History
  • Implied Volatility 183.61% ( +46.89%)
  • Historical Volatility 73.16%
  • IV Percentile 92%
  • IV Rank 41.80%
  • IV High 381.87% on 03/10/25
  • IV Low 41.21% on 09/11/24
  • Put/Call Vol Ratio 0.75
  • Today's Volume 442
  • Volume Avg (30-Day) 440
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 7,151
  • Open Int (30-Day) 12,826

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.70
  • Number of Estimates 2
  • High Estimate 1.14
  • Low Estimate 0.27
  • Prior Year 0.59
  • Growth Rate Est. (year over year) +18.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.53 +4.64%
on 03/28/25
Period Open: 7.48
7.61 -37.68%
on 03/03/25
-2.74 (-36.63%)
since 02/28/25
3-Month
4.53 +4.64%
on 03/28/25
Period Open: 9.56
11.98 -60.43%
on 01/24/25
-4.82 (-50.42%)
since 12/31/24
52-Week
1.82 +160.43%
on 04/18/24
Period Open: 2.30
15.10 -68.61%
on 07/30/24
+2.44 (+106.09%)
since 04/01/24

Most Recent Stories

More News
Emergent BioSolutions Announces Stock Repurchase Program

EBS : 4.74 (-2.47%)
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

EBS : 4.74 (-2.47%)
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

HIK.LN : 1,948.000 (-0.05%)
EBS : 4.74 (-2.47%)
HKMPY : 50.6000 (-2.82%)
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

EBS : 4.74 (-2.47%)
Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

EBS : 4.74 (-2.47%)
Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

EBS : 4.74 (-2.47%)
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

EBS : 4.74 (-2.47%)
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

EBS : 4.74 (-2.47%)
Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Jazz Pharmaceuticals JAZZ announced that it has entered into a definitive agreement to acquire all the outstanding shares of clinical-stage biotech Chimerix CMRX for $8.55 per share in cash, aggregating...

JAZZ : 124.99 (+0.68%)
EBS : 4.74 (-2.47%)
CMRX : 8.50 (-0.12%)

Business Summary

Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. It also supplies vaccines to domestic and international non-government organizations and governments in/ outside...

See More

Key Turning Points

3rd Resistance Point 5.25
2nd Resistance Point 5.11
1st Resistance Point 4.92
Last Price 4.74
1st Support Level 4.59
2nd Support Level 4.45
3rd Support Level 4.26

See More

52-Week High 15.10
Fibonacci 61.8% 10.03
Fibonacci 50% 8.46
Fibonacci 38.2% 6.89
Last Price 4.74
52-Week Low 1.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies